NCCN Guidelines for Patients® | Ovarian Cancer - page 60

60
Part 7: Recurrence treatment
NCCN Guidelines for Patients
®
: Ovarian cancer
Version 1.2013
Recurrence treatments
Recommended recurrence treatment regimens
Preferred
Other
Combination if platinum-sensitive
Carboplatin/paclitaxel
Carboplatin/weekly paclitaxel
Carboplatin/docetaxel
Carboplatin/gemcitabine
Carboplatin/gemcitabine/bevacizumab
Carboplatin/liposomal doxorubicin
Cisplatin/gemcitabine
Single agent if platinum-sensitive
Carboplatin
Cisplatin
Single agent if platinum-resistant
Docetaxel
Etoposide, oral
Gemcitabine
Liposomal doxorubicin
Paclitaxel, weekly
Topotecan
Targeted therapy
Bevacizumab
Single agents
Altretamine
Capecitabine
Cyclophosphamide
Ifosfamide
Irinotecan
Melphalan
Oxaliplatin
Paclitaxel
Nab-paclitaxel
Pemetrexed
Vinorelbine
Hormone therapy
Anastrozole
Letrozole
Leuprolide acetate
Megestrol acetate
Tamoxifen
1...,50,51,52,53,54,55,56,57,58,59 61,62,63,64,65,66,67,68,69,70,...100
Powered by FlippingBook